title: Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.
authors.affiliation: From the Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis (K.T.W.); and Program of Cardiovascular Diseases, Centre for Applied Medical Research (J.D.) and Department of Cardiology and Cardiac Surgery, University Clinic (J.D.), University of Navarra, Pamplona, Spain.
authors.forename: Karl T
authors.initials: KT
authors.lastname: Weber
authors.affiliation: From the Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis (K.T.W.); and Program of Cardiovascular Diseases, Centre for Applied Medical Research (J.D.) and Department of Cardiology and Cardiac Surgery, University Clinic (J.D.), University of Navarra, Pamplona, Spain. jadimar@unav.es.
authors.forename: Javier
authors.initials: J
authors.lastname: Díez
mesh_terms: D000818:Animals; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000066491:Clinical Decision-Making; D005355:Fibrosis; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D058990:Molecular Targeted Therapy; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D058628:Myofibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018579:Patient Selection; D057285:Precision Medicine / Q000379:methods*; D011506:Proteins / Q000378:metabolism*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D000077786:Torsemide; D020257:Ventricular Remodeling / Q000187:drug effects*
chemical_list: D002317:Cardiovascular Agents; D011506:Proteins; D013449:Sulfonamides; D000077786:Torsemide
keywords: angiotensin II; fibroblasts; fibrosis; heart failure; myofibroblasts